| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 7 | |
| #2 | Japan | 2 | |
| #3 | Brazil | 1 | |
| #4 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Analysing materials | |
| #5 | Microorganisms | |
| #6 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Seoane Suarez Joan | 5 |
| #2 | Anido Folgueira Judit | 5 |
| #3 | Hallett Robin Matthew | 3 |
| #4 | Baselga Torres Jose | 3 |
| #5 | Magram Jeanne | 2 |
| #6 | Parra Palau Josep Lluis | 2 |
| #7 | Pascual Garcia Monica | 2 |
| #8 | Angellini Pier-Davide | 2 |
| #9 | Planas Rigol Ester | 2 |
| #10 | Fransson Johan | 2 |
| Publication | Filing date | Title |
|---|---|---|
| AU2019269131A1 | Antibodies against LIF and dosage forms thereof | |
| AU2019251289A1 | Combination of LIF inhibitors and PD-1 axis inhibitors for use in treating cancer | |
| AU2017381585A1 | Antibodies against LIF and uses thereof | |
| JP2011121943A | Antibody against her2 truncated variant ctf-611 | |
| AU2009265921A1 | Method for diagnosing cancers expressing the HER2 receptor or its truncated variants |